Tissue plasminogen activator in Israel: Are we there yet?

Israel Medical Association Journal

Volumn 11, Issue 12, 2009, Pages 749-750

  Ben Hur, Tamir ^a   Leker, Ronen R ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Early reperfusion; Stroke; Stroke units; Tissue plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

EDITORIAL; HEALTH CARE; HEALTH CARE COST; HUMAN; MEDICAL DECISION MAKING; NEUROIMAGING; STROKE; TREATMENT OUTCOME;

HUMANS; ISRAEL; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 75449089700     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (6)

1. Hacke W, Donnan G, Fieschi C, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363(9411): 768-74.
2. Marler JR, Tilley BC, Lu M, et al. Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology 2000; 55(11): 1649-55.
3. Gur AY, Shopin L, Bornstein NM. Lessons learned from two years experience in intravenous thrombolysis for acute ischemic stroke in a single tertiary medical center. IMAJ Isr Med Assoc J 2009; 11: 714-18.
4. Gupta R, Vora NA, Horowitz MB, et al. Multi-modal reperfusion therapy for acute ischemic stroke: factors predicting vessel recanalization. Stroke 2006; 37(4): 986-90.
5. Leker RR, Eichel R, Arkadir D, et al. Multi-modal reperfusion therapy for patients with acute anterior circulation stroke in Israel. Stroke 2009; 40(11): 3627-30.
6. Raphaeli G, Eichel R, Ben-Hur T, Leker RR, Cohen JE. Multimodal reperfusion therapy in patients with acute basilar artery occlusion. Neurosurgery 2009; 65(3): 548-52; discussion 552.